Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
about
The role of vascular endothelial growth factor a polymorphisms in breast cancerThe effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies.Vascular endothelial growth factor receptor-2 in breast cancer.Lysine methylation promotes VEGFR-2 activation and angiogenesis.Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsCelecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signalingBreast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's PerspectivePilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer.Biomarkers and the genetics of early neoplastic lesions.Late recurrence of breast carcinoma metastasis to the hypopharynx: a case reportAngiogenesis-associated sequence variants relative to breast cancer recurrence and survival.VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK.Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.An Integrative Pathway-based Clinical-genomic Model for Cancer Survival Prediction.MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.Molecular mechanisms of hormone resistance of breast cancer.VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.
P2860
Q26851522-8E1BEABF-8924-4DE7-A4A2-416FBD7D25BFQ33372962-09179DB2-72D5-43A8-B7F4-07AE261BEE90Q33709284-111E4D51-85B6-4C4D-B230-C9F17E651B1EQ33912620-8E41C578-2509-4721-BA67-1DDD48EF52E6Q33940384-4DD06B07-A872-4D9B-A6A1-8534A06CB77AQ34082909-71C3FC21-784C-40C7-A17C-AC6351F257AFQ34753820-1D25D46B-6203-4C44-BE8C-2E12DEF7ED83Q35055683-C80A6BC3-A4A9-465F-B83C-D08A267228ECQ35671180-A6CEEE01-7703-40CC-8BD0-C80AA97D1F0FQ35947983-5933CB42-FC2C-4ABD-AC54-0453E2E9D1B7Q36340108-B19278A7-C7E2-4AF6-AB40-ECE147421391Q36894951-D0659657-0890-4526-A5F2-FD339ABA0FA1Q37304321-59F80CAE-CCDE-455F-AACF-D025EF42DD9CQ38661111-A99FE6DF-5734-4F41-8F23-C21835CC91B5Q38695524-37673C55-C267-4662-B128-97717632E1C7Q39090350-D65AB086-2E9E-4DF3-98B1-48EEA66B0BEFQ42776111-5722B80B-0C5E-420C-AF7C-586DD1B8A99BQ43184280-D5870EE6-7A0B-46C1-97BE-1BED75413EAAQ53025494-4FC243FC-18A5-491E-99D3-FB951CA3E21AQ53086084-DC49753F-4FAB-42C6-AD2E-0B95407301B7Q54341383-C13DD334-310C-4650-A21A-A69C270634FD
P2860
Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@en
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@nl
type
label
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@en
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@nl
prefLabel
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@en
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@nl
P2093
P1476
Tumor-specific VEGF-A and VEGF ...... athway and tamoxifen response.
@en
P2093
Göran Landberg
Håkan Jonsson
Lisa Rydén
Maria Stendahl
Nils O Bengtsson
Stefan Emdin
P2888
P304
P356
10.1007/S10549-004-1655-7
P407
P577
2005-01-01T00:00:00Z
P6179
1035506916